COX-2 inhibitors for colorectal cancer - PubMed (original) (raw)

• PMID: 9546780
• DOI: 10.1038/nm0498-392

COX-2 inhibitors for colorectal cancer

D J Elder et al. Nat Med. 1998 Apr.

No abstract available

PubMed Disclaimer

Similar articles

• Cyclooxygenase-2 as a target for prevention of colorectal cancer.
  Bertagnolli MM. Bertagnolli MM. Curr Oncol Rep. 1999;1(2):173-8. doi: 10.1007/s11912-999-0030-6. Curr Oncol Rep. 1999. PMID: 11122816 Review.
• COX-2 in large bowel cancer: a one-sided story.
  DuBOIS RN. DuBOIS RN. Gut. 1999 Nov;45(5):636-7. doi: 10.1136/gut.45.5.636. Gut. 1999. PMID: 10517891 Free PMC article. No abstract available.
• [COX-1 and COX-2: functions and pharmacological effects].
  Hinz B, Brune K. Hinz B, et al. Pharm Unserer Zeit. 1999 Jan;28(1):21-9. Pharm Unserer Zeit. 1999. PMID: 10078026 Review. German. No abstract available.
• New paradigms for cancer prevention.
  DuBois RN. DuBois RN. Carcinogenesis. 2001 May;22(5):691-2. doi: 10.1093/carcin/22.5.691. Carcinogenesis. 2001. PMID: 11323385 No abstract available.
• Role of cyclooxygenase inhibitors for the prevention of colorectal cancer.
  Stack E, DuBois RN. Stack E, et al. Gastroenterol Clin North Am. 2001 Dec;30(4):1001-10. doi: 10.1016/s0889-8553(05)70225-9. Gastroenterol Clin North Am. 2001. PMID: 11764529 Review.

Cited by

• Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation.
  Serebrennikova OB, Tsatsanis C, Mao C, Gounaris E, Ren W, Siracusa LD, Eliopoulos AG, Khazaie K, Tsichlis PN. Serebrennikova OB, et al. Proc Natl Acad Sci U S A. 2012 May 1;109(18):E1082-91. doi: 10.1073/pnas.1115098109. Epub 2012 Mar 26. Proc Natl Acad Sci U S A. 2012. PMID: 22451924 Free PMC article.
• Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals.
  Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN. Eliopoulos AG, et al. EMBO J. 2002 Sep 16;21(18):4831-40. doi: 10.1093/emboj/cdf478. EMBO J. 2002. PMID: 12234923 Free PMC article.
• Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.
  Shoji Y, Takahashi M, Kitamura T, Watanabe K, Kawamori T, Maruyama T, Sugimoto Y, Negishi M, Narumiya S, Sugimura T, Wakabayashi K. Shoji Y, et al. Gut. 2004 Aug;53(8):1151-8. doi: 10.1136/gut.2003.028787. Gut. 2004. PMID: 15247185 Free PMC article.
• Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.
  Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC, Schedin P. Lyons TR, et al. Nat Med. 2011 Aug 7;17(9):1109-15. doi: 10.1038/nm.2416. Nat Med. 2011. PMID: 21822285 Free PMC article.
• Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan.
  Cheng HH, Kuo CC, Yan JL, Chen HL, Lin WC, Wang KH, Tsai KK, Guvén H, Flaberg E, Szekely L, Klein G, Wu KK. Cheng HH, et al. Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13231-6. doi: 10.1073/pnas.1209919109. Epub 2012 Jul 31. Proc Natl Acad Sci U S A. 2012. PMID: 22851770 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program